Preparing for FDA's New Import/Export Trauma in 2020

Preparing for FDA's New Import/Export Trauma

19 March - 20 March, 2020

feedback@complianceonline.com

+1-888-717-2436

https://www.complianceonline.com/fdas-new-import-program-concerning-international-consequences-seminar-training-80133SEM-prdsm?channel=List-pharmaceutical-tech

San Francisco, United States

Organized By:


ComplianceOnline

+1-888-717-2436

feedback@complianceonline.com

www.complianceonline.com

2479 E. Bayshore Road Suite 260 Palo Alto, CA 94303, USA

About Preparing for FDA's New Import/Export Trauma

The FDA continues to change its import program to better manage new problems and to use new procedures to make the whole process easier. The FDA and U.S. Customs and Border Protection (CBP) are relying more and more on computer programs to expedite the import process. When and how you use these programs can make a big difference in the net profit derived from even a single shipment. The new Voluntary Qualified Importer Program (VQIP) is one such example. Another example is CBP’s and FDA’s implementation of the Automated Commercial Environment (ACE) program became mandatory for importers in 2016. If you fail to correctly use new import procedures and programs, you will be operating under an expensive disadvantage.

Speakers

speaker

-

Visitors Profile

  • Business Planning Executives
  • Regulatory Managers
  • In-house Legal Counsel and Contract Specialists
  • Venture Capitalists
  • Business Acquisition Executives
  • Owners of New or Developing Import/Export Firms
  • International Trade Managers
  • Import Brokers
  • Investors
  • Logistics Managers
  • Sales Managers

Register ( for this Event )

SSL Secure Connection